TozinameranWorsening of chronic graft-versus-host disease and steroid-refractory immune thrombocytopenia: 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1905卷 / 1期
关键词：
D O I：
10.1007/s40278-022-14877-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 487
相关论文
共 50 条
  • [31] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [32] Novel strategies for steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Vogelsang, GB
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 40 - 44
  • [33] Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease
    De la Garza-Salazar, Fernando
    Colunga-Pedraza, Perla Rocio
    Coronado-Alejandro, Edgar Ulises
    Gutierrez-Aguirre, Cesar Homero
    Cantu-Rodriguez, Olga Graciela
    Gomez-Almaguer, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (03) : 573 - 576
  • [34] MICA is not a direct humoral allogeneic target in steroid-refractory chronic graft-versus-host disease
    Whittle, R.
    Goodwin, J.
    Smillie, D.
    Harmer, A.
    Taylor, P.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2010, 37 (05) : 430 - 430
  • [35] Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab
    von Bonin, Malte
    Oelschlaegel, Uta
    Radke, Joergen
    Stewart, Michelle
    Ehninger, Gerhard
    Bornhauser, Martin
    Platzbecker, Uwe
    TRANSPLANTATION, 2008, 86 (06) : 875 - 879
  • [36] Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Blazar, Bruce R.
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 804 - 811
  • [37] Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
    Wang, Dong
    Liu, Yin
    Lai, Xiaoxuan
    Chen, Jia
    Cheng, Qiao
    Ma, Xiao
    Lin, Zhihong
    Wu, Depei
    Xu, Yang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [38] A Phase I Study of Alemtuzumab Dosing for Steroid-Refractory Chronic Graft-Versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey
    BLOOD, 2012, 120 (21)
  • [39] Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
    Chin, Kuo-Kai
    Kim, Haesook T.
    Inyang, Eno-Abasi
    Ho, Vincent
    Koreth, John
    Romee, Rizwan
    Gooptu, Mahasweta
    Shapiro, Roman
    Antin, Joseph
    Soiffer, Robert
    Jaglowski, Samantha
    Pidala, Joseph
    Cutler, Corey
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 990.e1 - 990.e7
  • [40] Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study
    Dal Sinan, Mehmet
    Batgi, Hikmettullah
    Erkurt, Mehmet Ali
    Hindilerden, Ipek Yonal
    Kuku, Irfan
    Kurtoglu, Erdal
    Kaya, Emin
    Besisik, Sevgi Kalayoglu
    Berber, Ilhami
    Nalcaci, Meliha
    Ulas, Turgay
    Altuntas, Fevzi
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (05)
12345